<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04533009</url>
  </required_header>
  <id_info>
    <org_study_id>2017-11-10</org_study_id>
    <nct_id>NCT04533009</nct_id>
  </id_info>
  <brief_title>Tramadol-paracetamol Combination in Treatment of Patients Undergoing Spinal Surgery</brief_title>
  <acronym>TRAMAPARAS</acronym>
  <official_title>Tramadol-paracetamol Combination in Treatment of Patients Undergoing Spinal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Eastern Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kuopio University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tramadol-paracetamol combination is studied in patients coming for elective spine surgery.&#xD;
      The study drug is started at the day of surgery and continued maximum of five days. Before&#xD;
      the surgery pain, use of pain medication, satisfaction for pain medication, adverse effects,&#xD;
      resilience, depression and life satisfaction were asked. At the discharge and seven days&#xD;
      after the surgery use of pain medication and adverse effects were asked. The patients were&#xD;
      followed up to 28 days and one year after surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised, double blinded, placebo controlled study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>placebo tablets are used</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Satisfaction for pain medication</measure>
    <time_frame>one week after surgery</time_frame>
    <description>satisfaction measured with numeral rating scale 0-10 (0=not satisfied, 10= totally satisfied</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>need for rescue pain medication</measure>
    <time_frame>one week after surgery</time_frame>
    <description>Measured as amount of other pain medicines used as rescue medicine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain assessment</measure>
    <time_frame>one week after surgery</time_frame>
    <description>Pain measered in numeral rating scale 0-10 (0= no pain, 10=worst pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse effects</measure>
    <time_frame>one week after surgery</time_frame>
    <description>Patient reported adverse reactions</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Pain assessment</measure>
    <time_frame>one year after surgery</time_frame>
    <description>Pain measered in numeral rating scale 0-10 (0= no pain, 10=worst pain)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>tramadol/acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tramadol-paracetamol two tablets 37,5mg/325mg twice daily up to five days for patients undergoing spinal surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo two tablets twice daily up to five days for patients undergoing spinal surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>spine surgery</intervention_name>
    <description>Tramadol-paracetamol 325mg/37,5mg two tablets twice daily</description>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_label>tramadol/acetaminophen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18-75 years,&#xD;
&#xD;
          -  BMI 18-35 kg/m2,&#xD;
&#xD;
          -  informed consent obtained,&#xD;
&#xD;
          -  elective spine surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age&lt;18 years or &gt;75 years&#xD;
&#xD;
          -  Hypersensitivity to anti-inflammatory drugs, paracetamol, tramadol or their auxiliary&#xD;
             substances&#xD;
&#xD;
          -  Acute or recovered hemorrhage in gastrointestinal tract or peptic ulcer&#xD;
&#xD;
          -  Hemorrhagic disease&#xD;
&#xD;
          -  Monoamineoxidase use in past two weeks&#xD;
&#xD;
          -  Epilepsy&#xD;
&#xD;
          -  Tendency to seizure&#xD;
&#xD;
          -  Anti-seizure drugs in use Liver or renal failure Reduction in lung function Alcohol,&#xD;
             drug or opioid addiction on record Acute intoxication due to alcohol, analgesics,&#xD;
             opioids or psychopharmacon Pregnancy or breastfeeding Investigators estimation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Merja Kokki, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kuopio University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Merja Kokki, PhD</last_name>
    <phone>+358447174764</phone>
    <email>merja.kokki@kuh.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <state>Northern Savo</state>
        <zip>70029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Merja Kokki, PhD</last_name>
      <phone>+358447174764</phone>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>May 4, 2018</study_first_submitted>
  <study_first_submitted_qc>August 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2020</study_first_posted>
  <last_update_submitted>August 26, 2020</last_update_submitted>
  <last_update_submitted_qc>August 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

